{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:32:47Z","timestamp":1740180767494,"version":"3.37.3"},"reference-count":43,"publisher":"Consilium Medicum","issue":"9","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Mineralocorticoid receptor antagonists have been successfully used for many years to treat patients with primary hyperaldosteronism, refractory arterial hypertension and chronic heart failure. The increased interest in this drug in recent years is due to new information about its antifibrotic and antiproliferative effects, both cardiac and extracardiac. The article also discusses the possibility of using spironolactone in patients with the new coronavirus infection SARS-CoV-2 (COVID-19).<\/jats:p>","DOI":"10.26442\/00403660.2021.09.201016","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T13:13:20Z","timestamp":1633871600000},"page":"1132-1137","source":"Crossref","is-referenced-by-count":0,"title":["New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects"],"prefix":"10.26442","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-6255","authenticated-orcid":false,"given":"Natalia A.","family":"Dragomiretskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9536-8307","authenticated-orcid":false,"given":"Aida I.","family":"Tarzimanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4701-9473","authenticated-orcid":false,"given":"Julia S.","family":"Kucherova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0758-5609","authenticated-orcid":false,"given":"Valery I.","family":"Podzolkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"ref1","unstructured":"Kagawa CM, Sturtevant FM, Van Arman CG. Pharmacology of a new steroid that blocks salt activity of aldosterone and desoxycorticosterone. J Pharmacol Exp Ther. 1959;126(2):123-30."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/IBPC.S13783"},{"key":"ref3","unstructured":"\u041f\u043e\u0434\u0437\u043e\u043b\u043a\u043e\u0432 \u0412.\u0418., \u0411\u0443\u043b\u0430\u0442\u043e\u0432 \u0412.\u0410. \u0420\u0435\u043d\u0438\u043d-\u0430\u043d\u0433\u0438\u043e\u0442\u0435\u043d\u0437\u0438\u043d-\u0430\u043b\u044c\u0434\u043e\u0441\u0442\u0435\u0440\u043e\u043d\u043e\u0432\u0430\u044f \u0441\u0438\u0441\u0442\u0435\u043c\u0430 \u043a\u0430\u043a \u043a\u0440\u0430\u0435\u0443\u0433\u043e\u043b\u044c\u043d\u044b\u0439 \u043a\u0430\u043c\u0435\u043d\u044c \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u043e\u0433\u043e \u0438 \u043f\u043e\u0447\u0435\u0447\u043d\u043e\u0433\u043e \u043a\u043e\u043d\u0442\u0438\u043d\u0443\u0443\u043c\u0430. \u041e\u0440\u0433\u0430\u043d\u043e\u043f\u0440\u043e\u0442\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u0435 \u0441\u0432\u043e\u0439\u0441\u0442\u0432\u0430 \u0430\u043d\u0442\u0430\u0433\u043e\u043d\u0438\u0441\u0442\u043e\u0432 \u0440\u0435\u0446\u0435\u043f\u0442\u043e\u0440\u043e\u0432 \u043a \u0430\u043d\u0433\u0438\u043e\u0442\u0435\u043d\u0437\u0438\u043d\u0443 II. \u0410\u0442\u043c\u043e\u0441\u0444\u0435\u0440\u0430. \u041d\u043e\u0432\u043e\u0441\u0442\u0438 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0438. 2005;3:20-5 [Podzolkov VI, Bulatov VA. The renin-angiotensin-aldosterone system as a cornerstone of the cardiovascular and renal continuum. Organoprotective properties of angiotensin II receptor antagonists. Atmosphere. Cardiology News. 2005;3:20-5 (in Russian)]."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Ferrario CM. Cardiac remodelling and RAS inhibition. Ther Adv Cardiovasc Dis. 2016;10(3):162-71.","DOI":"10.1177\/1753944716642677"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10437"},{"key":"ref6","unstructured":"Food and drug administration center for drug evaluation and research cardiovascular and renal drugs: advisory committee (CRDAC) meeting. Virtual Meeting Wednesday, December 16, 2020 9:00 a.m. to 1:37 p.m. Available at: https:\/\/www.fda.gov\/media\/146717\/download. Accessed: 21.08.2021."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.20996\/1819-6446-2017-13-2-263-269"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101227"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ph14010071"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-016-9591-2"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.01.017"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11887.1"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-7125(03)00168-8"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2011.02531.x"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3353"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01060"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30319-4"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-017-0600-2"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs587"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30071-8"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/2047487316675194"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.12.158"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.22.2700"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.18087\/cardio.2475"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv464"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011942"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.09.009"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1194"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa758"},{"key":"ref33","unstructured":"Haenel J. The effect of aldactone on advanced respiratory insufficiency (respiratory acidosis) in chronic cor pulmonale. Munch Med Wochenschr. 1963;105:2179-85 (in German)."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2013.08.019"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S100095"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154262"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.15252\/embj.20105114"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2020.04.031"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1210\/me.2013-109"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.18087\/cardio.2020.11.n1440"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00453"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13152"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/82988\/63484","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/82988\/63484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T04:11:00Z","timestamp":1634098260000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/82988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,15]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2021.09.201016","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"type":"electronic","value":"2309-5342"},{"type":"print","value":"0040-3660"}],"subject":[],"published":{"date-parts":[[2021,9,15]]}}}